Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy

被引:18
|
作者
Grootjans, Willem [1 ,2 ]
Usmanij, Edwin A. [1 ]
Oyen, Wim J. G. [1 ,3 ,4 ]
van der Heijden, Erik H. F. M. [5 ]
Visser, Eric P. [1 ]
Visvikis, Dimitris [6 ]
Hatt, Mathieu [6 ]
Bussink, Johan [7 ]
de Geus-Oei, Lioe-Fee [1 ,2 ,8 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands
[3] Inst Canc Res, London, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Med, Nijmegen, Netherlands
[6] INSERM, UMR 1101, Lab Traitement Informat Med LaTIM, Brest, France
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Twente, MIRA Inst, Biomed Photon Imaging Grp, Enschede, Netherlands
关键词
Early response monitoring; Non-small cell lung cancer; Concomitant chemoradiochemotherapy; F-18-FDG PET/CT; Total lesion glycolysis; Automatic image segmentation; TARGET VOLUME DELINEATION; RADIOTHERAPY FDG-PET; F-18-FDG PET; PROGNOSTIC VALUE; DOSE-ESCALATION; SURVIVAL; FAILURE; IMPACT; NSCLC; AREAS;
D O I
10.1016/j.radonc.2016.04.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study evaluated the use of total lesion glycolysis (TLG) determined by different automatic segmentation algorithms, for early response monitoring in non-small cell lung cancer (NSCLC) patients during concomitant chemoradiotherapy. Materials and methods: Twenty-seven patients with locally advanced NSCLC treated with concomitant chemoradiotherapy underwent F-18-fluorodeoxyglucose (FDG) PET/CT imaging before and in the second week of treatment. Segmentation of the primary tumours and lymph nodes was performed using fixed threshold segmentation at (i) 40% SUVmax (T40), (ii) 50% SUVmax (T50), (iii) relative-threshold-level (RTL), (iv) signal-to-background ratio (SBR), and (v) fuzzy locally adaptive Bayesian (FLAB) segmentation. Association of primary tumour TLG (TLGT), lymph node TLG (TLGLN), summed TLG (TLG(S) = TLG(T) + TLG(LN)), and relative TLG decrease (Delta TLG) with overall -survival (OS) and progression-free survival (PFS) was determined using univariate Cox regression models. Results: Pretreatment TLG(T) was predictive for PFS and OS, irrespective of the segmentation method used. Inclusion of TLG(LN) improved disease and early response assessment, with pretreatment TLG(S) more strongly associated with PFS and OS than TLG(T) for all segmentation algorithms. This was also the case for Delta TLG(S), which was significantly associated with PFS and OS, with the exception of RTL and T40. Conclusions: Delta TLG(S) was significantly associated with PFS and OS, except for RTL and T40. Inclusion of TLG(LN) improves early treatment response monitoring during concomitant chemoradiotherapy with FDG-PET. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:473 / 479
页数:13
相关论文
共 50 条
  • [1] Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy
    Zaizen, Yoshiaki
    Azuma, Koichi
    Kurata, Seiji
    Sadashima, Eiji
    Hattori, Satoshi
    Sasada, Tetsuro
    Imamura, Yohei
    Kaida, Hayato
    Kawahara, Akihiko
    Kinoshita, Takashi
    Ishibashi, Masatoshi
    Hoshino, Tomoaki
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (12) : 4179 - 4184
  • [2] 18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
    Usmanij, Edwin A.
    de Geus-Oei, Lioe-Fee
    Troost, Esther G. C.
    Peters-Bax, Liesbeth
    van der Heijden, Erik H. F. M.
    Kaanders, Johannes H. A. M.
    Oyen, Wim J. G.
    Schuurbiers, Olga C. J.
    Bussink, Johan
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (09) : 1528 - 1534
  • [3] Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer
    Yildirim, Fatma
    Yurdakul, Ahmet Selim
    Ozkaya, Sevket
    Akdemir, Umit Ozguer
    Ozturk, Can
    CLINICAL RESPIRATORY JOURNAL, 2017, 11 (05): : 602 - 611
  • [4] Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer
    Vokes, EE
    ONCOLOGIST, 2001, 6 : 25 - 27
  • [5] eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
    Buma, Alessandra I. G.
    Muller, Mirte
    de Vries, Rianne
    Sterk, Peter J.
    van der Noort, Vincent
    Wolf-Lansdorf, Marguerite
    Farzan, Niloufar
    Baas, Paul
    van den Heuvel, Michel M.
    LUNG CANCER, 2021, 160 : 36 - 43
  • [6] Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib
    Kahraman, Deniz
    Holstein, Arne
    Scheffler, Matthias
    Zander, Thomas
    Nogova, Lucia
    Lammertsma, Adriaan A.
    Boellaard, Ronald
    Neumaier, Bernd
    Dietlein, Markus
    Wolf, Juegen
    Kobe, Carsten
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (11) : 1058 - 1064
  • [7] A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy
    Jochems, Arthur
    El-Naqa, Issam
    Kessler, Marc
    Mayo, Charles S.
    Jolly, Shruti
    Matuszak, Martha
    Faivre-Finn, Corinne
    Price, Gareth
    Holloway, Lois
    Vinod, Shalini
    Field, Matthew
    Barakat, Mohamed Samir
    Thwaites, David
    de Ruysscher, Dirk
    Dekker, Andre
    Lambin, Philippe
    ACTA ONCOLOGICA, 2018, 57 (02) : 226 - 230
  • [8] Chemoradiotherapy in Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer
    Linhas, Ana
    Dias, Margarida
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S857 - S858
  • [9] Clinical Efficacy of Bevacizumab Concomitant with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer
    Zhang, Yu-Mei
    Li, Yong-Qiang
    Liu, Zhi-Hui
    Liao, Xiao-Li
    Liang, Rong
    Lin, Yan
    Yuan, Chun-Ling
    Liao, Si-Na
    Liang, Chao-Yong
    Li, Qian
    Li, Le-Qun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3447 - 3450
  • [10] Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent Chemoradiotherapy
    Huang, Huei-Tyng
    Nix, Michael G.
    Brand, Douglas H.
    Cobben, David
    Hiley, Crispin T.
    Fenwick, John D.
    Hawkins, Maria A.
    CANCERS, 2022, 14 (19)